PMC Stock Overview
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Pharmedic Pharmaceutical Medicinal Joint Stock Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₫113,200.00 |
52 Week High | ₫135,800.00 |
52 Week Low | ₫73,600.00 |
Beta | 0.38 |
1 Month Change | -0.53% |
3 Month Change | 7.30% |
1 Year Change | 39.75% |
3 Year Change | 71.52% |
5 Year Change | 104.33% |
Change since IPO | 91.77% |
Recent News & Updates
Recent updates
Shareholder Returns
PMC | VN Pharmaceuticals | VN Market | |
---|---|---|---|
7D | -10.4% | -0.4% | 1.5% |
1Y | 39.8% | 23.3% | 6.8% |
Return vs Industry: PMC exceeded the VN Pharmaceuticals industry which returned 23% over the past year.
Return vs Market: PMC exceeded the VN Market which returned 5.3% over the past year.
Price Volatility
PMC volatility | |
---|---|
PMC Average Weekly Movement | 7.2% |
Pharmaceuticals Industry Average Movement | 4.6% |
Market Average Movement | 4.0% |
10% most volatile stocks in VN Market | 7.6% |
10% least volatile stocks in VN Market | 2.2% |
Stable Share Price: PMC's share price has been volatile over the past 3 months compared to the VN market.
Volatility Over Time: PMC's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of VN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 534 | Tran Trung | www.pharmedic.com.vn |
Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also provides functional foods; medicine from herbs; eyes, ears, nose, throat, cough treatment; disinfectant and antiseptic; anti-allergic and anaphylactic drugs; digestive tract and liver drugs; topical; antiparasitic and antibacterial drugs; pain reliever, fever reducer, anti-inflammatory, gout treatment; and neurological drugs.
Pharmedic Pharmaceutical Medicinal Joint Stock Company Fundamentals Summary
PMC fundamental statistics | |
---|---|
Market cap | ₫1.06t |
Earnings (TTM) | ₫80.13b |
Revenue (TTM) | ₫498.18b |
13.2x
P/E Ratio2.1x
P/S RatioIs PMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PMC income statement (TTM) | |
---|---|
Revenue | ₫498.18b |
Cost of Revenue | ₫310.97b |
Gross Profit | ₫187.21b |
Other Expenses | ₫107.08b |
Earnings | ₫80.13b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 8.59k |
Gross Margin | 37.58% |
Net Profit Margin | 16.09% |
Debt/Equity Ratio | 0% |
How did PMC perform over the long term?
See historical performance and comparisonDividends
16.9%
Current Dividend Yield82%
Payout RatioDoes PMC pay a reliable dividends?
See PMC dividend history and benchmarksPharmedic Pharmaceutical Medicinal dividend dates | |
---|---|
Ex Dividend Date | Feb 18 2025 |
Dividend Pay Date | Feb 28 2025 |
Days until Ex dividend | 4 days |
Days until Dividend pay date | 6 days |
Does PMC pay a reliable dividends?
See PMC dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/21 04:50 |
End of Day Share Price | 2025/02/21 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharmedic Pharmaceutical Medicinal Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.